CN112156222B - 一种止血抗菌促愈合的冷冻凝胶海绵制备方法 - Google Patents
一种止血抗菌促愈合的冷冻凝胶海绵制备方法 Download PDFInfo
- Publication number
- CN112156222B CN112156222B CN202011002342.9A CN202011002342A CN112156222B CN 112156222 B CN112156222 B CN 112156222B CN 202011002342 A CN202011002342 A CN 202011002342A CN 112156222 B CN112156222 B CN 112156222B
- Authority
- CN
- China
- Prior art keywords
- sponge
- mbg
- qcs
- hemostatic
- cryogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000499 gel Substances 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 27
- 239000000243 solution Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229920001661 Chitosan Polymers 0.000 claims abstract description 25
- 239000000495 cryogel Substances 0.000 claims abstract description 23
- 239000008346 aqueous phase Substances 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims abstract description 13
- 230000001737 promoting effect Effects 0.000 claims abstract description 10
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000005313 bioactive glass Substances 0.000 claims abstract description 9
- 230000035876 healing Effects 0.000 claims abstract description 9
- 239000002105 nanoparticle Substances 0.000 claims abstract description 9
- 239000011148 porous material Substances 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- 239000000017 hydrogel Substances 0.000 claims abstract description 8
- 230000004048 modification Effects 0.000 claims abstract description 7
- 238000012986 modification Methods 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 5
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 claims abstract description 4
- 238000004132 cross linking Methods 0.000 claims abstract description 3
- 238000003980 solgel method Methods 0.000 claims abstract description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 2
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 239000003431 cross linking reagent Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 abstract description 6
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 7
- 238000002329 infrared spectrum Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000005576 amination reaction Methods 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 239000004530 micro-emulsion Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- -1 ethyl acetate-hexadecyltrimethylamine bromide-water Chemical compound 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000006386 memory function Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000009344 Penetrating Wounds Diseases 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
- A61L24/0089—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Composite Materials (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011002342.9A CN112156222B (zh) | 2020-09-22 | 2020-09-22 | 一种止血抗菌促愈合的冷冻凝胶海绵制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011002342.9A CN112156222B (zh) | 2020-09-22 | 2020-09-22 | 一种止血抗菌促愈合的冷冻凝胶海绵制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112156222A CN112156222A (zh) | 2021-01-01 |
CN112156222B true CN112156222B (zh) | 2021-10-26 |
Family
ID=73863376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011002342.9A Active CN112156222B (zh) | 2020-09-22 | 2020-09-22 | 一种止血抗菌促愈合的冷冻凝胶海绵制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112156222B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113817214A (zh) * | 2021-08-06 | 2021-12-21 | 广东省科学院健康医学研究所 | 一种多孔水凝胶海绵及其制备方法和应用 |
CN113599573A (zh) * | 2021-09-07 | 2021-11-05 | 贵州医科大学 | 一种急救用形变记忆多孔水凝胶止血材料及其制备方法 |
CN114452438A (zh) * | 2022-01-21 | 2022-05-10 | 佛山今兰生物科技有限公司 | 一种生物活性玻璃复合多孔冷冻凝胶微球及其制备和应用 |
CN116554537A (zh) * | 2022-01-30 | 2023-08-08 | 武汉大学 | 一种甲壳素/壳聚糖基止血材料的制备方法 |
CN115487344B (zh) * | 2022-09-29 | 2023-11-07 | 西北农林科技大学深圳研究院 | 一种具有监测和治疗功能的抗菌止血冷冻凝胶 |
CN115779133A (zh) * | 2022-10-24 | 2023-03-14 | 华南理工大学 | 快速吸水与良好生物相容性的止血冷冻凝胶的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101314039A (zh) * | 2008-07-03 | 2008-12-03 | 华南理工大学 | 一种生物活性玻璃介孔微球及其制备方法 |
WO2009032884A1 (en) * | 2007-09-05 | 2009-03-12 | Z-Medica Corporation | Wound healing with zeolite-based hemostatic devices |
CN101991875A (zh) * | 2010-10-29 | 2011-03-30 | 上海硅健生物材料有限公司 | 介孔生物活性玻璃和壳聚糖复合多孔止血材料及制备方法 |
CN102319448A (zh) * | 2011-09-16 | 2012-01-18 | 华中科技大学 | 一种用于制备医用创伤敷料的抗菌水凝胶材料及其制备方法 |
CN106178090A (zh) * | 2016-07-26 | 2016-12-07 | 四川艾医生医疗科技有限公司 | 一种生物活性妇科栓塞及其制备方法 |
CN107320768A (zh) * | 2017-06-30 | 2017-11-07 | 广州润虹医药科技股份有限公司 | 用于创伤修复含有干细胞提取物的敷料及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG173537A1 (en) * | 2009-04-01 | 2011-09-29 | Colgate Palmolive Co | Dentifrice compositions and methods for treating and preventing damage to tooth surfaces |
CN103601907B (zh) * | 2013-11-22 | 2015-03-04 | 哈尔滨工业大学 | 一种超疏水颗粒/壳聚糖骨架复合吸油海绵的制备方法 |
CN107441551B (zh) * | 2017-09-01 | 2020-05-19 | 西安交通大学 | 一种碳纳米管增强的可注射抗菌导电纳米复合止血晶胶敷料及其制备方法和应用 |
CN110151784A (zh) * | 2019-04-19 | 2019-08-23 | 浙江科技学院 | 一种用于伤口护理的载碘生物活性玻璃及其应用 |
CN110420350B (zh) * | 2019-08-28 | 2021-10-22 | 深圳先进技术研究院 | 复合生物玻璃的粘附温敏水凝胶及其制备方法和应用 |
-
2020
- 2020-09-22 CN CN202011002342.9A patent/CN112156222B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009032884A1 (en) * | 2007-09-05 | 2009-03-12 | Z-Medica Corporation | Wound healing with zeolite-based hemostatic devices |
CN101314039A (zh) * | 2008-07-03 | 2008-12-03 | 华南理工大学 | 一种生物活性玻璃介孔微球及其制备方法 |
CN101991875A (zh) * | 2010-10-29 | 2011-03-30 | 上海硅健生物材料有限公司 | 介孔生物活性玻璃和壳聚糖复合多孔止血材料及制备方法 |
CN102319448A (zh) * | 2011-09-16 | 2012-01-18 | 华中科技大学 | 一种用于制备医用创伤敷料的抗菌水凝胶材料及其制备方法 |
CN106178090A (zh) * | 2016-07-26 | 2016-12-07 | 四川艾医生医疗科技有限公司 | 一种生物活性妇科栓塞及其制备方法 |
CN107320768A (zh) * | 2017-06-30 | 2017-11-07 | 广州润虹医药科技股份有限公司 | 用于创伤修复含有干细胞提取物的敷料及其制备方法 |
Non-Patent Citations (1)
Title |
---|
季铵化壳聚糖止血海绵制备工艺的研究;李继城等;《化学推进剂与高分子材料》;20171231;第15卷(第3期);摘要、第68页左栏第1段至第71页右栏第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN112156222A (zh) | 2021-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112156222B (zh) | 一种止血抗菌促愈合的冷冻凝胶海绵制备方法 | |
Qiu et al. | Nanofibers reinforced injectable hydrogel with self-healing, antibacterial, and hemostatic properties for chronic wound healing | |
CN111632190B (zh) | 一种医用生物凝胶止血敷料的制备方法 | |
CN111019162A (zh) | 以氧化透明质酸为交联剂的壳聚糖多肽衍生物自交联水凝胶的制备方法及应用 | |
Song et al. | Kaolin-loaded carboxymethyl chitosan/sodium alginate composite sponges for rapid hemostasis | |
CN108636374B (zh) | 一种多巴胺接枝磺化海藻酸钠双交联微球及其制备方法和用途 | |
Dong et al. | Facile preparation of a thermosensitive and antibiofouling physically crosslinked hydrogel/powder for wound healing | |
CN113908328B (zh) | 一种基于海藻酸钠、纳晶纤维素的抗菌止血多孔微球 | |
CN111690078B (zh) | 双季铵化壳聚糖衍生物及其合成方法、包含其的复合海绵生物敷料与应用 | |
CN110747534A (zh) | 一种抗菌多糖纤维材料及其制备方法 | |
Wang et al. | Calcium alginate/silk fibroin peptide/Bletilla striata polysaccharide blended microspheres loaded with tannic acid for rapid wound healing | |
CN113069589A (zh) | 一种可生物降解的抗菌止血海绵 | |
CN110975001B (zh) | 壳聚糖-纤维素复合止血海绵及制备方法和应用 | |
CN114479124B (zh) | 一种可自愈水凝胶、其制备方法及应用 | |
CN112979999B (zh) | 生物大分子及改性埃洛石复合水凝胶及其制备和应用 | |
CN114832153A (zh) | 多糖类织物增强基抗菌止血多功能水凝胶敷料 | |
CN109045347B (zh) | 一种可降解的载药止血微球及其制备方法 | |
CN112057667A (zh) | 一种可降解吸收的生物止血材料 | |
CN115386135B (zh) | 一种羧甲基化酵母多糖海绵及其制备方法和应用 | |
CN117258030B (zh) | 一种牛角瓜纤维基水凝胶敷料及其制备方法和用途 | |
Wu et al. | The study of double-network carboxymethyl chitosan/sodium alginate based cryogels for rapid hemostasis in noncompressible hemorrhage | |
CN115779133A (zh) | 快速吸水与良好生物相容性的止血冷冻凝胶的制备方法 | |
Hu et al. | Optimized preparation of carboxymethyl chitosan/sodium alginate hemostatic microcapsule | |
CN115671373B (zh) | GelMA-DA/季铵化壳聚糖/甘油复合止血海绵材料及其制备方法 | |
CN113975455B (zh) | 一种可吸收止血粉和制备方法及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220401 Address after: 518000 Fubao community, Fubao street, Futian District, Shenzhen, Guangdong A03, first floor, Fubao logistics building, east of Taohua Road, Futian Free Trade Zone, Shenzhen Patentee after: Tootheng Biotechnology (Shenzhen) Co.,Ltd. Address before: 510640 No. five, 381 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: SOUTH CHINA University OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230519 Address after: 510640 No. five, 381 mountain road, Guangzhou, Guangdong, Tianhe District Patentee after: SOUTH CHINA University OF TECHNOLOGY Address before: 518000 Fubao community, Fubao street, Futian District, Shenzhen, Guangdong A03, first floor, Fubao logistics building, east of Taohua Road, Futian Free Trade Zone, Shenzhen Patentee before: Tootheng Biotechnology (Shenzhen) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240520 Address after: No. 13 Incubation Park, Songjiang Industrial Agglomeration Zone, Yancheng District, Luohe City, Henan Province, 462000 Patentee after: HENAN AINA MEDICAL TECHNOLOGY CO.,LTD. Country or region after: China Address before: 510640 No. five, 381 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: SOUTH CHINA University OF TECHNOLOGY Country or region before: China |